Ayman Refaie
Impact in
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
- Genetics top 5%
- Mesenchymal stem cell research
- Diabetes and associated disorders
Papers in
-
- Renal Transplantation Outcomes and Treatments 27
- Genetics 13
- Mesenchymal stem cell research 13
- Co-authors
- Mohamed A. GhoneimMahmoud M. GabrMahmoud M. ZakariaMohamed SobhM. IsmailSherry M. KhaterSylvia A. AshamallahMohamed A. Bakr
- Journals
- BioMed Research International (5 papers)American Journal of Nephrology (4 papers)Stem Cell Research & Therapy (2 papers)Cell Transplantation (2 papers)British Journal of Urology (2 papers)
- Partner nations
- EgyptUnited StatesUnited Kingdom
In The Last Decade
Ayman Refaie
65 papers receiving 901 citations
Peers
Comparison fields: 5 of 85
- Transplantation 135
- Genetics 161
- Nephrology 92
- Surgery 422
- Endocrinology, Diabetes and Metabolism 131
Countries citing papers authored by Ayman Refaie
This map shows the geographic impact of Ayman Refaie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Refaie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Refaie more than expected).
Fields of papers citing papers by Ayman Refaie
This network shows the impact of papers produced by Ayman Refaie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Refaie. The network helps show where Ayman Refaie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ayman Refaie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 21 | |
| 3 | 2022 | 11 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 35 | |
| 8 | 2019 | 4 | |
| 9 | 2019 | 3 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 7 | |
| 13 | 2016 | 14 | |
| 14 | 2015 | 10 | |
| 15 | Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant. | 2011 | 7 |
| 16 | 2004 | 3 | |
| 17 | 2003 | 37 | |
| 18 | 1997 | 1 | |
| 19 | 1996 | 3 | |
| 20 | 1994 | 21 |
About Ayman Refaie
Ayman Refaie is a scholar working on Transplantation, Genetics, Nephrology, Hepatology and Surgery, having authored 72 papers that have together received 921 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (27 papers), Pancreatic function and diabetes (18 papers), Mesenchymal stem cell research (13 papers), Organ Donation and Transplantation (11 papers), Organ Transplantation Techniques and Outcomes (8 papers), Neurological Complications and Syndromes (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Renal and Vascular Pathologies (6 papers). The work is most often cited by research in Transplantation (135 citations), Genetics (161 citations), Nephrology (92 citations), Surgery (422 citations) and Endocrinology, Diabetes and Metabolism (131 citations). Ayman Refaie has collaborated with scholars based in Egypt, United States and United Kingdom. Frequent co-authors include Mohamed A. Ghoneim, Mahmoud M. Gabr, Mahmoud M. Zakaria, Mohamed Sobh, M. Ismail, Sherry M. Khater, Mohamed A. Ghoneim, Sylvia A. Ashamallah, Mohamed A. Bakr and Ahmed A. Shokeir. Their work appears in journals such as BioMed Research International, American Journal of Nephrology, Stem Cell Research & Therapy, Cell Transplantation and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.